The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
Clinical trial NCT03236649 · TERMINATED
Trial details
- NCT number
- NCT03236649
- Sponsor
- Beijing Shenogen Biomedical Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2022-02-08
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.